← Evidence map

ArticleFrontiers in neurology2020

Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain.

Angel P Sempere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33519676